CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist

250.25
+3.26+1.32%

Market Closed Apr 3 15:00 CST

100.35BMarket Cap27.07P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical Q4 2024 Earnings Date

Currency：CNYMar 29, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	160.16M	--
		-13.04%
Net Income	--	-357.86M	--
		-34.84%

Analyst Rating

Strong Buy

Apr 5, 2025

Sichuan Biokin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 2.748B	--
--	2025/FY	-- / 2.243B	--
Mar 29, 2025	2024/FY	5.823B / 6.051B	--
--	2023/FY	561.871M / 562.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 2.748B--

--2025/FY-- / 2.243B--

Mar 29, 20252024/FY5.823B / 6.051B--

--2023/FY561.871M / 562.000M--

--------

Unlock Free Earnings Estimates

Open Account

Sichuan Biokin Pharmaceutical Earnings Reports

SiChuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Report.

Mar 28 12:00 ET

Summary of the 2024 Annual Report of SiChuan Baili Tianheng Pharmaceutical Co., Ltd.

Mar 28 12:00 ET

Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Results Express Announcement

Feb 27 11:00 ET

Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Results Express Announcement